Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-27
2007-11-27
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253100, C514S254020, C514S254030, C544S363000, C544S364000, C544S367000, C544S369000
Reexamination Certificate
active
11649156
ABSTRACT:
Substituted 1-propiolylpiperazine compounds corresponding to formula Iin which X denotes N or C—R2, and n is an integer from 0 to 8, a method for producing such substituted 1-propiolylpiperazine compounds, pharmaceutical compositions containing such substituted 1-propiolylpiperazine compounds, and the use of such substituted 1-propiolylpiperazine compounds for modulating mGluR5 receptor activity or for treating or inhibiting pain and various other conditions, especially conditions at least partly mediated by the mGluR5 receptor.
REFERENCES:
patent: 0 552 418 (1993-07-01), None
patent: WO 01/32690 (2001-05-01), None
patent: WO 2003/093236 (2003-11-01), None
patent: WO 2004/029044 (2004-04-01), None
PCT/IPEA/409 (International Preliminary Report On Patentability) with English translation (Eleven (11) Pages).
Susana Morales-Alcelay et al., “AMPA Glutamate Receptors and Neuropathic Pain”Mini Reviews in Medicinal Chemistry, Bentham Science Publishers Hilversum, NL, vol. 3, No. 7, Nov. 2003, pp. 757-763.
Michael Williams et al., “Emerging Molecular Approaches to Pain Therapy” Journal of Medicinal Chemistry, vol. 42, No. 9, 1999, pp. 1481-1500, XP-002344884.
Camille G. Wermuth, “Molecular Variations Based on Isosteric Replacements” The Practice of Medicinal Chemistry, 1996, pp. 203-237, XP-002190259.
G.L. Regnier et al., “Triphenylpropylpiperazine Derivatives as new Potent Analgetic Substances”, Journal of Medicinal Chemistry, vol. 15, No. 3, 1972, pp. 295-301.
Jon L. Collins et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγ Agonists. 2. Structure-Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety”, Journal of Medicinal Chemistry, vol. 41, No. 25, 1998, pp. 5037-5054.
Theodora W. Greene et al. “Protective Groups in Organic Synthesis” 3rdEdition, Table of Contents, 1999, Wiley, New York.
Philip J. Kocieński “Protecting Groups” 3rdEdition, Table of Contents, 2005, Georg Thieme Verlag, Stuttgart.
Alfonso R. Gennaro, “Remington's Pharmaceutical Sciences”, 17thEdition, Table of Contents, Mack Publishing Company, Easton, PA, 1985.
David Dubuisson et al. “The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats”, Pain, 4, 1977, pp. 161-174, Elsevier/North-Holland Biomedical Press.
International Search Report dated Sep. 27, 2005 (Three (3) pages).
German Search Report dated Oct. 22, 2004 with an English translation of the pertinent portions (Eight (8) pages).
Haurand Michael
Jostock Ruth
Kuehnert Sven
Oberboersch Stefan
Schiene Klaus
Gruenenthal GmbH
Powers Fiona T
LandOfFree
Substituted 1-propiolylpiperazine compounds, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-propiolylpiperazine compounds, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-propiolylpiperazine compounds, their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3860482